(Photo Courtesy: www.dukechildrens.org)
Around 85 to 90 percent of such cases can be detected if pregnant mothers opt for genetic screening.
To address this, NACE (Non-Invasive Analysis for Chromosomal Examination) is a new technology which can accurately detect chromosomally linked diseases like Down's syndrome with a simple blood test.
Opines Dr Prathima Radhakrishna, director, Bangalore Fetal Medicine Center, Bengaluru, "The main advantage of using NACE is that it is non-invasive and it poses near zero-risk to fetus and has no risk of abortion."
It can precisely tell a pregnant mother, as early as three months into her pregnancy, whether her child suffers from Down's syndrome.
According to Dr Pere Mir, medical director, Iviomics India, "NACE is a revolutionary screening test offering a highly accurate analysis by using the latest next-generation sequencing technology. This simple and safe analysis averts the risk of fetal loss present in amniocentesis procedure."